Table 1 Patient’s clinicopathological characteristics of RATG and LATG group for AGC
Characteristics | RATG (n = 99) | LATG (n = 106) | P value |
|---|---|---|---|
Gender (n, %) | 0.335 | ||
Male | 58 (58.6) | 55 (51.9) | |
Female | 41 (41.4) | 51 (48.1) | |
Age (mean ± SD, years) | 58.7 ± 6.7 | 59.0 ± 7.3 | 0.743 |
Body mass index (median and range, kg/m2) | 23.9 (17.3–28.6) | 23.9 (19.9–28.3) | 0.548 |
location of neoplasm (n, %) | 0.350 | ||
Corpora ventriculi | 66 (66.7) | 64 (62.7) | |
Fundus ventriculi | 33 (33.3) | 42 (37.3) | |
T stage (n, %) | 0.840 | ||
2 | 26 (26.3) | 28 (26.4) | |
3 | 40 (40.4) | 39 (36.8) | |
4 | 33 (33.3) | 39 (36.8) | |
N stage (n, %) | 0.861 | ||
0 | 30 (30.3) | 28 (26.4) | |
1 | 30 (30.3) | 29 (27.4) | |
2 | 16 (16.2) | 18 (17.0) | |
3a | 16 (16.2) | 20 (18.9) | |
3b | 7 (7.1) | 11 (10.4) | |
pTNM (n, %) | 0.376 | ||
1b | 2 (2.0) | 3 (2.8) | |
2a | 23 (23.2) | 22 (20.8) | |
2b | 31 (31.3) | 29 (27.4) | |
3a | 27 (27.3) | 24 (22.6) | |
3b | 13 (13.1) | 17 (16.0) | |
3c | 3 (3.0) | 11 (10.4) | |
ASA score (n, %) | 0.900 | ||
1 | 52 (52.5) | 53 (50.0) | |
2 | 40 (40.4) | 44 (41.5) | |
3 | 7 (7.1) | 9 (8.5) | |
diameter of neoplasm (mm) | 47.6 ± 12.7 | 47.0 ± 12.4 | 0.763 |